Preservation with 8-bromo-cyclic GMP improves pulmonary function after prolonged ischemia Robert C King, MD, Victor E Laubach, PhD, R.Chai Kanithanon, BA, Adam M Kron, Patrick E Parrino, MD, Kimberly S Shockey, MS, Curtis G Tribble, MD, Irving L Kron, MD The Annals of Thoracic Surgery Volume 66, Issue 5, Pages 1732-1738 (November 1998) DOI: 10.1016/S0003-4975(98)00991-6
Fig 1 Pulmonary artery pressures for the four experimental groups during 30 minutes of reperfusion: group 1 = immediate control (); group 2 = 18-hour control (■); group 3 = cyclic guanosine monophosphate analogue (cGMP) treatment and 18-hour storage (▴); and group 4, cGMP treatment and 30-hour storage (▾). The Annals of Thoracic Surgery 1998 66, 1732-1738DOI: (10.1016/S0003-4975(98)00991-6)
Fig 2 Pulmonary venous–arterial oxygen gradients for the four experimental groups at 10, 20, and 30 minutes of reperfusion: group 1 = immediate control (□); group 2 = 18 hour control (■); group 3 = cyclic guanosine monophosphate analogue (cGMP) treatment and 18-hour storage (▤); and group 4 = cGMP treatment and 30-hour storage (). The Annals of Thoracic Surgery 1998 66, 1732-1738DOI: (10.1016/S0003-4975(98)00991-6)